Exceed™ Microneedling system by Candela  is a high-precision, medical-grade device designed for microneedling treatments aimed at improving skin texture, reducing scars, and minimizing signs of aging. As a Class II medical device, the Exceed system is FDA-cleared, which means it has been rigorously tested for safety and efficacy. Its motorized, adjustable needle depths allow for precise, customizable treatments tailored to each patient’s unique skin needs.

The device operates by using ultra-fine needles to create controlled micro-injuries in the skin. These micro-injuries stimulate the body’s natural wound-healing process, encouraging collagen and elastin production, which are essential proteins for skin strength, elasticity, and a smoother appearance. This treatment is commonly used to address fine lines, acne scars, and wrinkles, as well as to improve overall skin tone and texture.

What sets Exceed™ apart is its adaptability and comfort. The needle depth can be adjusted between 0.5mm to 2.0mm, allowing it to effectively treat different skin layers. Exceed’s design minimizes trauma to the skin’s surface, and with its variable speed settings, it can cater to different skin sensitivities, making the experience more comfortable for patients. The device is also known for reducing post-treatment downtime, as most patients experience only mild redness for 24–48 hours following the procedure.

1-3 Treatment with the Exceed™ system is customizable and minimally invasive, suitable for healthy men and women to treat the appearance of facial wrinkles and facial acne scars. In only 4 treatments, 90% of patients saw an improvement in facial wrinkles and 86% of patients showed significant improvement in their facial acne scars. The treatment is well tolerated with minimal pain, discomfort or downtime, all in under an hour.

Patients that are undergoing treatment with the Exceed™ system should be sure to: discontinue anticoagulant therapy, Aspirin or high-dose nonsteroidal anti–inflammatory drugs (NSAIDS) for 14 days prior to treatment. If you have a history of cold sores, please inform your provider as you may need to be pretreated with an antiviral medication. Discontinue topical retinoids or other skin irritants for a minimum of 3-5 days prior to treatment. Avoid prolonged sun exposure and use SPF 30. 

Immediately post treatment, the localized pin-point bleeding should subside within 5-10 minutes of treatment. Pain or discomfort may occur with gradual cessation following the treatment. Transient mild to moderate erythema (redness) and edema (swelling) can last for up to 6 days. Other inflammatory responses such as itching, warming, flaking or peeling can occur and will typically subsides within 8 days of treatment

• Patients should be advised of the expected healing sequence and expected treatment side effects as detailed in the User Manual’s Clinical Guide. 
• Immediately following treatment, cleanse the treated area with sterile NS and gauze. 
• Apply Provider’s choice of healing dressing to the treated areas as per standard medical procedure.
• For the first week and until completely healed, cleanse the treatment area with Provider’s choice of gentle cleanser and pat dry, do not rub. 
• Avoid washcloths, harsh irritants, and scrubs until the treated area is completely healed. 
• Reapply healing dressing as needed throughout the day. The treated area should be kept as hydrated as possible for one-week post treatment. 
• Avoid excessive sun exposure to the treatment area and gently pat in a sunblock of at least SPF 30 or higher at all times for at least one month following the procedure
• Do not pick at the treated area. It is imperative to let the area heal on its own. If the area is picked at and further interruption of the epidermal layer occurs, this can increase the risk of infection, PIH, and other post procedure complications.
• Patients should be advised to contact their provider if they have any concerns about how their skin is responding to the treatment or is healing.